Le Lézard
Classified in: Health
Subject: TDS

WaveFire Announces the Launch of its Innovative Risk Management Platform


NASHVILLE, Tenn., August 22, 2019 /PRNewswire-PRWeb/ -- WaveFire, LLC, today announced the launch of a cross-industry innovative platform empowering risk management for cybersecurity, compliance and audit., supporting multiple regulatory frameworks. Early-access Fortune 500 retail and healthcare clients report significant reduction in the burden of risk assessment by leveraging the WaveFire platform and validate that the technology facilitates comprehensive and efficient assessments.

The founders designed the WaveFire platform, drawing upon deep compliance, audit, and security consulting and software as a service (SaaS) development experience. They have consulted with clients nationwide on risk assessments and have built an intuitive platform for organizations to assess, manage, and remediate risks across the entire enterprise for multiple frameworks. WaveFire founder, Damon Work, says, "Our multi-location clients were challenged to assess risks, measure compliance, and prepare for audits. We designed a platform that has helped our clients transform their assessment processes from many months to a few weeks."

The WaveFire platform facilitates a quick configuration of questions and fast implementation. Technology lead and founder, Tim Wickstrom, explains further, "The WaveFire platform allows our users to easily disseminate relevant questions to the right control owners, who can apply the response to multiple locations, business units, and frameworks as appropriate. Additionally, because the platform is so intuitive, users have been able to assess multiple frameworks throughout every level of the organization."

Since acting on risks is key to any program, the WaveFire platform includes a dashboard with real-time results that give interim and final results with a clear view of areas that need remediation. Unique in the industry, the users can adjust weighting/scoring to support the organization's priorities. After the assessment is complete, users can use the platform to document, track, and report risk mitigation activities for ongoing improvement in compliance and risk management.

Details of the platform are shared on the organization's new website, WaveFire.com.

About WaveFire
The WaveFire platform empowers risk management for cybersecurity, compliance, and audit by rapidly evaluating every entity and stakeholder across the entire enterprise for multiple frameworks simultaneously. WaveFire supports frameworks such as HIPAA, NIST, GDPR, and many more. WaveFire's risk assessments give visibility into disparate locations, shared services, business units, and the processes used deep in the organization. WaveFire empowers organizations to reduce risks, increase security, and maintain regulatory compliance. To learn more, visit WaveFire.com.

SOURCE WaveFire


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: